Timothy Coughlin Travere Therapeutics, Inc. (TVTX) insider trading activity

Timothy Coughlin is of Travere Therapeutics, Inc.. Currently has a direct ownership of 55,500 shares of TVTX, which is worth approximately $966,255. The most recent transaction as insider was on May 15, 2025, when has been sold 6,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.5K

13.27% 3M change

13.27% 12M change

Total Value Held $966,255

TIMOTHY COUGHLIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2025	BUY Grant, award, or other acquisition	-	6,500 Added 10.48%	55,500 Common Stock
May 08 2024	BUY Grant, award, or other acquisition	-	6,500 Added 11.71%	49,000 Common Stock
May 17 2023	BUY Grant, award, or other acquisition	-	4,500 Added 9.57%	42,500 Common Stock
May 11 2022	BUY Grant, award, or other acquisition	-	3,000 Added 7.32%	38,000 Common Stock
May 14 2021	BUY Grant, award, or other acquisition	-	3,000 Added 7.89%	35,000 Common Stock

Also insider at

LIFE

aTYR PHARMA INC Healthcare

FATE

FATE THERAPEUTICS INC Healthcare

ADCT

ADC Therapeutics SA Healthcare

Director